Select the directory option from the above "Directory" header!

​Start-up Spotlight - Meet the emerging tech businesses of Australia

​Start-up Spotlight - Meet the emerging tech businesses of Australia

ARN examines the tech start-ups rising to prominence across the country.

In reflection of the increased levels of innovation across the industry, this column uncovers the emerging start-ups changing the face of the channel in Australia.


Robert McLeay - Founder and CTO, DoseMe
Robert McLeay - Founder and CTO, DoseMe

FOUNDED — 2015
KEY TECH — Cloud
KEY VENDORS — Microsoft, Charm Health, Atlassian, Google, Apple and Dell EMC
KEY CUSTOMERS — Barwon Health (Victoria), St Vincent's Hospital (Sydney) and University Hospital Maribor (Slovenia)

Since its founding less than two years ago, DoseMe has helped local and global hospitals become more efficient.

After pioneering the first individualised dosing decision support software for the healthcare sector in the world, the Queensland-based start-up is aiming to double its current workforce of ten by the end of 2017, in light of continuing expansion plans.

The cloud-based service, hosted on Microsoft Azure, allows clinicians to predict an accurate dose for many classes of drugs from as little as one laboratory result.

The software works by digitally constructing a virtual model of a patient’s individual pharmacokinetics and pharmacodynamics and compares thousands of data points from published population models.

“We started the business because drug dosing is complicated — 60 per cent of doses in hospitals are incorrect,” DoseMe founder and CTO Robert McLeay explained.

“The technology for individualised dosing existed but it just wasn’t usable. There is a big opportunity in health for digital disruption — paper charts and hand medication charts are still in use in the majority of Australian hospitals.

“DoseMe software is saleable with electronic patient management systems and with rich data analytics on drug effectiveness enabling continuous improvement.”

In targeting the healthcare sector, the software also supports hospital pharmacists, infectious disease specialists and oncology specialists.

“Our key goal for 2017 is to gain regulatory clearance for sale in the US,” McLeay added.


Andrew Thomas - Founder and CEO, AtlasPlato
Andrew Thomas - Founder and CEO, AtlasPlato

FOUNDED — 2017
KEY TECH — Business intelligence, data analytics artificial intelligence, machine learning
KEY VENDORS — Splunk and Domo

Just over a year after selling Thomas Duryea Consulting, serial entrepreneur Andrew Thomas has launched a new business intelligence (BI) focused start-up.

Under the banner of AtlasPlato, the new business aims to solve “the biggest problems of the world” through data solutions.

Since founding Thomas Duryea in 2000, and in selling storage-based services to over 500 customers in Australia, one thing became clear for Thomas — what about the data?

“Customers would ask — can we delete it?” he recalled. “Why are we keeping so much data? We would be asked to assess it, age it and archive it and we started to understand that once 90 days clicked past, most people don’t access their data and their storage is just ever-increasing.”

Inspired by the infinite possibilities of emerging intelligent technologies such machine learning and artificial intelligence, Thomas said a core aim of AtlasPlato is to build expertise around specific verticals.

“We will start to sell disruptive products and provide services around them,” he explained. “As we sell solutions into insurance for example, we will gain a greater understanding of the vertical and create an advantage from there. The same applies to healthcare, finance, education etc.”

Since officially launching in early February 2017, AtlasPlato is already collaborating with vendors such as Splunk and Domo.

Follow Us

Join the newsletter!


Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.
Show Comments